The various enzymatic reactions by means of which the bacterium Escherichia coli converts erythrose-4-phosphate and phosphoenolpyruvate to chorismate are now well established (13, 25) . Chorismate is a key intermediate in aromatic biosynthesis, because it is the last intermediate in the common pathway and, as such, can be converted enzymatically via a number of different pathways into the end products tyrosine, phenylalanine, tryptophan, ubiquinone, vitamin K, and folic acid (5, 6, 10, 11).
Mutant strains blocked in any of the reactions leading to chorismate show a multiple requirement for two or more of the aromatic amino acids and vitamins depending on the completeness of the block. Such mutants have been referred to as multiple aromatic auxotrophs as distinct from strains blocked in any of the specific pathways leading from chorismate to tryptophan, phenylalanine, or tyrosine, these latter strains being known as tryptophan auxotrophs or phenylalanine auxotrophs, etc.
Very little is known about the distribution on the E. coli chromosome of the structural genes for each of the enzymes involved in the reactions of the common pathway. The mutations carried by some aromatic mutants have been mapped (24) , but, since no biochemical investigations were carried out, the functions of the mapped genes were unknown. It is the purpose of this communication to describe the chromosomal location and the specific function of five of the aro genes concerned with the common pathway and of one of the phe and one of the tyr genes concerned with the phenylalanine and tyrosine pathways, respectively. (For a description of symbols used, see Table 1 .) Some of these mutant strains have been obtained from A. L. Taylor, some from R. Somerville, and the rest have been isolated in these laboratories.
To locate the genes on the chromosome, we have used both interrupted mating techniques and phage Plkc-mediated transductions (this phage will subsequently be referred to as P1). The data from interrupted mating experiments make it possible to assign to a gene a definite chromosomal location, and this method has been used in the construction of most chromosomal maps. The accuracy of the method, however, does not make it possible to distinguish genes that are separated by less than 1 to 2 % of the E. coli genome. Since the E. coli chromosome may contain as many as 5,000 genes, mutations separated by less than 50 genes may not be separable by this method.
Phage P1 is unable to cotransduce two chromosomal markers that are separated by more than approximately 2% of the E. coli genome. When two markers are cotransducible, however, an estimation of the distance between them can be made by measuring the frequency with which they are separated by recombination events. This may be measured by use of a wild-type donor with a recipient that carries both mutant alleles, in which AROMATIC BIOSYNTHESIS IN E. COLI case the frequency at which the wild-type alleles are cotransduced will vary inversely with the distance that separates them. This distance may also be measured if one mutation is present in the donor strain and the other in the recipient. In this case, the frequency with which wild-type transductants are obtained will vary directly with the distance that separates the two mutations. In general, transduction studies involving P22-Salmonella typhimurium systems and P1-E. coli systems indicate that, if two mutations occur in a single gene, then the frequency with which wildtype transductants are obtained in crosses between mutants will vary between about 5 and 0% of that obtained with wild-type donor phage, depending on the relative positions of the mutations within the gene (15, 21, 28 (0) xyl-mal-str-pur C-his-try-pro-leuilv-sex factor AB311 (0) his-try-pro-leu-ilv-xyl-mal-str-pur C-sex factor AB259 (0) leu-pro-try-his-pur C-str-mal-xylilv-sex factor * For abbreviations, see first footnote in (19) . Syntrophism tests. The method described by Gibson and Jones (12) was used.
Isolation of mutants. The method described by Adelberg and Meyers (3) was used. In most cases, ultraviolet light was the mutagenic agent, but, in some cases, it was N-methyl-N'-nitro-N-nitrosoguanidine. When the latter mutagen was used, the procedure described by Adelberg, Mandel, and Chen (2) was followed.
Preparation of cell-free extracts. Cells harvested from 18-hr cultures were washed with chilled 0.9% NaCl and then suspended in 4 ml per 1 g (wet weight) of either 0.1 M Tris (pH 7.8) or 0.1 M phosphate buffer (pH 7.6). Cell breakage was achieved by forcing cells through a French press at a pressure of20,000 psi.
Cell-free extracts were obtained after centrifugation at 21,600 X g for 20 min, and were stored at -20 C.
Column chromatography of enzymes. This was carried out by use of the method described by Cotton and Gibson (5) .
Assay of dehydroquinate (DHQ) synthetase. The method described by Srinivasan and Sprinson (23) was used.
Assay of dehydroquinase. The method described by Mitsuhashi and Davis (17) was used. In these assays, since no dehydroquinic acid was available, the substrate for the reaction was the filtered supernatant fluid containing the accumulation products of E. coli 83-1 (see 26) .
Assay of dehydroshikimate (DHS) reductase. The method described by Yaniv and Gilvarg (27) jAmoles; cell-free extract, 1 to 2 mg of protein; 0.05 M Veronal buffer (pH 9.0) to a total volume of 2.0 ml.
Kinase activity was determined by measuring the disappearance of shikimate according to the method of Gaitonde and Gordon (9) .
Estimation of shikimate-5-phosphate. This was measured by conversion to shikimate with alkaline phosphatase according to the method of Morgan, Gibson, and Gibson (18) .
Assay of 3 -enolpyruvyl -shikimate -5 -phosphate (EPSP) synthetase and chorismate synthetase. Since EPSP was not available for use as a substrate, cellfree extracts were examined for their ability to carry out the overall conversion of shikimate to anthranilate. The general conditions used for this assay have already been described by Morgan et al. (18) . Shikimate was used rather than shikimate-5-phosphate as it was readily available, and all the strains being examined were tested for their ability to convert shikimate to shikimate-5-phosphate. Anthranilate was measured rather than chorismate because of the ease and sensitivity of its fluorimetric estimation. Although some of the chorismate formed from shikimate can be converted to prephenate by these extracts, this amount was kept to a minimum by preparing cell-free extracts from cells in which anthranilate synthetase was derepressed. This was achieved by growing cells in a minimal medium containing excess tyrosine and phenylalanine (2 X 10-4 M), p-aminobenzoic and p-hydroxybenzoic acids (2 X 10-6 M), and limiting indole at a concentration of 1.5 X 10-5 M.
Complementation tests. Cell-free extracts unable to carry out the overall conversion of shikimate to anthranilate were mixed in various combinations and tested for their ability to complement each other in the overall reaction. As a result of these tests, cellfree extracts could be directed into two groups (groups I and II), significant conversion of shikimate to anthranilate only being observed when extracts from both groups were present.
Identification ofenzyme activities present in cell-free extracts of groups I and II. To establish which enzymatic activities were missing from extracts of groups I and II, complementation tests were carried out in which different extracts were added sequentially. In these tests, 0.2 ml of a cell-free extract from one group was added to the reaction mixture and incubated at 37 C for 40 min. The incubation mixture was then heated at 100 C for 5 min and then cooled to 37 C (step 1). Then 0.2 ml of an extract from the other group was added, and the reaction mixture was again incubated at 37 C for 40 min (step 2). The anthranilate formed was measured as described for anthranilate synthetase. Anthranilate will only be formed when the extract added first is able to convert shikimate to EPSP (i.e., possessing full activity for EPSP synthetase), and when the extract added last possesses full activity for chorismate synthetase. Table 3 .
Biochemical analysis of mutant strains blocked before shikimate. Those strains showing a complete or partial response to shikimate were tested for their ability to cross-feed each other (Table 4) . These strains were then examined for their ability to carry out the second, third, and fourth reactions of the common pathway. The results of these enzyme assays are shown in Table 5 . As can be seen, the assays clearly indicate three different groups of mutants, each blocked in a separate reaction. The existence of three different phenotypes amongst these mutants had already been suggested by the cross-feeding data. It is of interest that the group whose aromatic requirements can only be partially satisfied by shikimic acid, and which cross-feeds the other two groups, lacks DHS reductase activity. Similar inability of strains blocked between DHS and shikimate to grow on shikimic acid alone has already been reported by Davis (7) .
Genetic analysis ofmutant strains blocked before shikimate. Somerville (personal communication) has already shown that the mutations affecting strains AB2826, AB2827, and AB2828 occurred in genes which were carried in different transducing fragments by phage P1. We determined the c Although unable to grow on shikimic acid alone, or on a mixture of phenylalanine and tyrosine, these strains grow well on shikimic acid, phenylalanine, and tyrosine.
d Although phenylalanine markedly stimulates growth of this organism, it grows slowly in the absence of phenylalanine. Table 6 . To confirm that both AT2472 and AB2828 carried mutations in the same gene (aro E), transductions were carried out between these strains. The results of Table 7 the transduction frequency was reduced to 8 % of the wild-type frequency. Both these results are compatible with the idea that the mutations of strains AB2828 and AT2472 occur within the same gene (aro E). This conclusion is further supported by the biochemical data.
The aro D gene (the structural gene for dehydroquinase) is transferred distally to his by Hfr AB313, and hence as an early marker by the Hfr AB311 (see Table 2 ). In interrupted mating experiments, with the male strain AB311 as donor and either AB1360 or AB2848 as recipients, the aro D gene was transferred at 14 min. Since the time of entry for his in these experiments was 8 min, these results confirmed the earlier observations of Taylor and Thoman (24) . The results of transduction tests confirming the close linkage of mutations affecting AB2848 and AB1360 are given in Table 8 .
Biochemical analysis of mutant strains unable to respond to shikimic acid but requiring two or more aromatic amino acids for growth. Extracts of these strains were initially examined for their ability to The results of these shikimate kinase assays are included in Table 10 .
Complementation between extracts. Since these strains could be blocked in either EPSP synthetase or in chorismate synthetase, different extracts were mixed together to determine whether pairs AB347 was demonstrated by mixing an extract of AB347 with an extract of strain AB2858 and measuring the combined kinase activity. The specific activity of the mixture was found to equal the mean of the two separate specific activities (Table 10) .
As no kinase mutants have yet been reported in the literature, it was decided to try to determine whether the reduced kinase activity of strain AB347 was associated with its loss of chorismate synthetase activity. It seemed possible that, if the kinase gene and the chorismate synthetase gene were contiguous, either a polarity mutation in one gene or a deletion extending into both might have caused the loss of the chorismate synthetase and the reduction of the kinase activity. To test this notion the aro+ allele from a wild-type strain was introduced into strain AB347 by transduction, recombinants being selected on minimal media not supplemented with the aromatic amino acids. A similar transduction was carried out with strain AB2830 as a recipient. This strain is also a group I mutant deficient in chorismate synthetase, but possessing full kinase activity. Two aro+ transductants in each case were purified, and then examined for their kinase activity. The extracts prepared from the aro+ transductants of AB347 had only one-fourth the kinase activity of the aro+ transductants prepared from strain AB2830. From this, then, we inferred that the kinase gene and the chorismate synthetase genes are not contiguous and that the reduced kinase levels in extracts of AB347 can not be explained Table 9 ). Group I mutants. The results of an interrupted mating experiment between one member of group I, AB2849, and the Hfr AB313 are shown in Fig.  4 . This gene affecting chorismate synthetase activity we have termed aro C. Transduction experiments demonstrating that all members of group I carry mutations in the aro C gene are shown in Table 13 . On the basis of interrupted mating experiments, Taylor and Thoman (24) placed the mutations affecting AB347 and AB477, which are present in their strains AB444 and AB1320, approximately 3.5 min apart on the chromosome, and designated them aro C and aro B, respectively. However, in this study, aro+ transductants were formed at less than 1 % wildtype frequency in crosses between these mutants (Table 13 ). Furthermore, in other transduction experiments, we have been able to show that the aro Cl allele of AB477 and the aro C4 allele of AB347 are both cotransduced with pur C at frequencies of 38 and 36%, respectively. Because of this latter result we have retained the aro C designation rather than the aro B for these mutations.
Group II mutants. The mutations carried by two group II mutants, AB478 and AB2856, and affecting EPSP synthetase were mapped in interrupted mating experiments using the male strain AB259. In both cases, the time of entry of this gene, aro A, was 30 min, which is in agreement with the results of Taylor and Thoman (24) . Transduction experiments demonstrating that all members of group II carry mutations in the aro A gene are given in Tables 14 and 15 . Biochemical analysis of mutant strains blocked between chorismate and phenylalanine. Three mutants of this class were examined. Of these, AT2022 and AT2092 were both obtained from Dr. Taylor, and AB2861, from Dr. Somerville. Cotton and Gibson (5) have shown in Aerobacter aerogenes and in E. coli W that there are two chorismate mutase enzymes that are separable when cell-free extracts are chromatographed on diethylaminoethyl (DEAE)-cellulose columns. They have also shown that prephenate dehydrogenase activity is associated with one peak and prephenate dehydratase activity with the other. We found a similar situation in E. coli K-12, and the chromatographic separation of these enzymes from cell-free extracts of a wildtype strain is shown in Fig. 5 . Figure 6 shows a similar experiment involving extracts from the phenylalanine auxotroph AT2022. It can be seen that one of the chorismate mutase peaks and its corresponding dehydratase activity are missing from extracts of the phenylalanine auxotroph. Extracts of the phenylalanine auxotroph strain AT2092 show a similar loss of prephenate dehydratase and its corresponding chorismate mutase peak (Cotton, personal communication (24) .
Biochemical analysis of mutant strains blocked between chorismate and tyrosine. We examined only three strains blocked in tyrosine biosynthesis: AT2471, AT2273, and AB2859. When extracts of AT2471 were chromatographed as already described for the phenylalanine auxotrophs, the chorismate mutase peak with its corresponding prephenate dehydrogenase activity was found to be missing (Fig. 7) . We (24) .
Since interrupted mating experiments indicated various markers are transferred by both these Hfr strains can be seen in Table 2 . Strain AB311 transferred the his 1+ allele and the his 4+ allele at 6 min; i.e., the 6.5-min difference between these markers had now disappeared. Unfortunately, strain AB311 transfers the phe A+ and phe B+ allele as distal markers, and it was not possible to check the difference in times of entry observed for phe A+ and phe B+. On the basis of these results, Taylor and Thoman have proposed that (i) the his 1+ and his 4+ alleles are normally less than 1 min apart, but in Hfr AB313 the his 4 allele has undergone a transposition, and (ii) that the two mutations affecting phenylalanine biosynthesis occur in two distinct genes separated by approximately 6 min on the chromosome.
As we have already shown, transduction tests demonstrate that the phe A and the phe B mutations occur, in fact, in the same gene. In other words, the 6-min difference in the times of entry of phe A+ and phe B+ found in the crosses with AB313 has to be accounted for by a hypothesis which will also explain the observed difference in the times of entry of his J+ and his 4+ alleles. In the crosses involving AT2092 and AT2022, selection was also made for the early markers xyl+ or mal+, and the times of entry obtained for these markers indicated that each one was entering either recipient at approximately the same time. Therefore, we cannot explain the 6-min difference by postulating that the initation of chromosome transfer is delayed by 6 min when strain AT2092 is the recipient. What we do propose, however, is that recipient strains are able to affect the rate at which the chromosome is transferred from the male donor, and that in matings involving the recipient AT2022 this rate is depressed. To explain the identical time of entry for early markers in these crosses, it is necessary to postulate that this alteration of rates of transfer affects distal markers much more than it does proximal ones. This hypothesis will also explain the differences in times of entry for the alleles that we have referred fo as aro Cl+ and aro C4+. We have at present no direct evidence in support of this hypothesis, but, in view of our results, it seems more acceptable than the transposition postulated by Taylor and Thoman.
We have not examined any of our mutant The map ofS. typhimurium is based on the publication ofSanderson and Demerec (20) . The functions of the different aromatic genes have not been described, and the gene symbols used, e.g., aro A etc., need not correspond to similar gene designations on the E. coli map. The parentheses around a symbol signify that the position is only known approximately. The map ofE. coli K-12 is constructed from our own data and that of Taylor and Thoman (24) . A description of the functions of the various genes is to be founid in Fig. I (20) have recently published a genetic map of Salmonella typhimurium, in which they listed five aromatic loci: aro A, aro B, aro C, aro D, and aro E. Since they present neither genetic nor biochemical evidence in support of separate gene designations for aro A and aro E on the one hand and aro B and aro C on the other (in each case the pair of genes being separated by less than 1 min on the chromosome), it is not possible to examine their claim that the distribution and function of the aromatic loci on the chromosomes of both E. coli and S. typhimurium are probably both the same. If each genetic locus that they refer to controls the structure of a different enzyme, then it appears as though divergence may exist between the two organisms as far as these loci are concerned. A comparison of the S. typhimurium map and the E. coli map is shown in Fig. 8 .
ADDENDUM IN PROOF
We have recently isolated a mutant strain which, although able to grow on minimal media alone, has a strict requirement for tyrosine in the presence of phenylalanine and tryptophan. Either dehydroquinic acid or shikimic acid can replace tyrosine as a growth factor. It is probable that this mutant has lost the tyrosine sensitive isoenzyme which converts erythrose-4-PO4 and phosphoenolpyruvate to PKDH. This new gene, for which we propose the designation aro-F, is cotransducible with the phe A gene at a frequency of 50% and with the tyr A gene at a frequency of 60%. Hence, two genes controlling two of the first specific reactions after the branch point and one of the genes involved in the first specific reaction of the common pathway are situated very close together on the chromosome. The significance of this arrangement for the regulation of this pathway is currently under investigation.
